News
IceCure (ICCM) Q2 2025 Earnings Call Transcript
Revenue -- Revenue (GAAP) totaled approximately $1.25 million for the six months ended June 30, 2025, down from $1.75 million in 2024, including over $200,000 in shipments delayed in Q2 2025 due to the Israeli-Iran conflict; this revenue is expected to be recognized in Q3 2025.
The average net positivity score for the Big Four was higher in the second quarter than it has been in at least a year. Click ...
StockStory.org on MSN5h
Unpacking Q2 Earnings: Tesla (NASDAQ:TSLA) In The Context Of Other Automobile Manufacturing Stocks
Looking back on automobile manufacturing stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including ...
The New York-based Eastman Kodak company says there's "substantial doubt" over its future after 2025's second-quarter ...
Nvidia Corporation may surpass Q2 EPS estimates, but China market risks and high valuation raise concerns. Click for my NVDA ...
StockStory.org on MSN3h
Gilead Sciences’s Q2 Earnings Call: Our Top 5 Analyst Questions
Gilead Sciences delivered a better-than-expected second quarter, propelled by the strong performance of its HIV portfolio and ...
Key Points Revenue (GAAP) of $13.0 million for Q2 FY2025 exceeded estimates by 9.7%, reflecting robust sequential growth from $9.7 million in Q1 FY2025. Gross margin (GAAP) fell sharply to 38.5% in Q2 ...
Image Source: Zacks Investment Research Q2 Earnings Season Scorecard As noted earlier, we have already seen fiscal May-quarter results from 18 S&P 500 members, which we count as part of our Q2 ...
CoreWeave extended its winning streak to a third day on Monday, jumping 7.9 percent to finish at $139.78 apiece as investors ...
Rigel's Q2 results highlight soaring revenue and raised guidance for 2025. See more on RIGL stock's growth potential, ...
The strong bank results have helped push the Q2 earnings growth expectation higher, with earnings for the S&P 500 index now expected to increase by +5.7% from the same period last year on +4.2% ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback